EVH
Evolent Health Inc
3.50$
-2.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +207.6% | +293.0% | -4.0% | +162.4% | +71.1% | +44.2% | +9.6% | +34.6% | -1.8% | +48.9% | +45.3% | +30.1% | -26.6% | |
| – | +166.3% | +143.6% | -21.5% | +170.4% | +73.6% | +21.7% | +56.5% | +35.8% | -5.6% | +57.5% | +45.2% | +45.5% | -27.2% | |
| – | – | – | +42.2% | +150.8% | +67.3% | +80.7% | -41.8% | +31.0% | +9.8% | +26.4% | +45.4% | -20.2% | -22.7% | |
| – | – | +100.0% | +45.0% | +91.4% | +55.0% | +5.8% | +8.8% | +22.7% | +9.1% | +1.9% | -1.1% | – | – | |
| – | – | +390.5% | -1.6% | +113.4% | +28.0% | +48.9% | +28.2% | -20.9% | -29.3% | +12.0% | +45.7% | -26.5% | +15.5% | |
| – | +0.7% | -250.2% | – | +115.8% | +33.8% | +47.4% | +37.7% | +1.6% | -40.4% | +6.9% | +69.9% | -23.3% | -29.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -2,055.3% | – | – | |
| – | – | -100.0% | – | +146.8% | +402.9% | +50.8% | +165.4% | +94.6% | -10.2% | -38.8% | +248.1% | -54.4% | +132.5% | |
| – | – | -226.0% | – | -169.2% | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | -145.8% | – | – | -57,087.5% | – | – | -9,080.5% | – | – | – | |
| – | – | -226.1% | – | -148.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -21.4% | -156.7% | – | -525.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.